These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 7656145
1. Protective effect of a specific PAF antagonist on vincristine-induced experimental retinopathy. Doly M, Cluzel J, Bonhomme B, Millerin M, Braquet P. Acta Ophthalmol Scand; 1995 Apr; 73(2):155-7. PubMed ID: 7656145 [Abstract] [Full Text] [Related]
3. Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730. Doly M, Cluzel J, Millerin M, Bonhomme B, Braquet P. Ophthalmic Res; 1993 Apr; 25(5):314-8. PubMed ID: 8259265 [Abstract] [Full Text] [Related]
4. [Involvement of PAF (Platelet-Activating Factor) in chloroquine-induced retinopathy]. Meyniel G, Doly M, Millerin M, Braquet P. C R Acad Sci III; 1992 Apr; 314(2):61-5. PubMed ID: 1559183 [Abstract] [Full Text] [Related]
10. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist. Doly M, Bonhomme B, Braquet P, Chabrier PE, Meyniel G. Immunopharmacology; 1987 Jun; 13(3):189-94. PubMed ID: 3038784 [Abstract] [Full Text] [Related]
11. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH. J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914 [Abstract] [Full Text] [Related]
12. Treatment of carrageenan induced arthritis by the platelet activating factor antagonist BN 50730. Hilliquin P, Natour J, Aissa J, Guinot P, Laoussadi S, Benveniste J, Menkes CJ, Arnoux B. Ann Rheum Dis; 1995 Feb; 54(2):140-3. PubMed ID: 7702404 [Abstract] [Full Text] [Related]
13. Formation of a highly stable complex between BN 50730 [tetrahydro-4,7,8,10 methyl-1(chloro-2 phenyl)-6 (methoxy-4 phenyl-carbamoyl)-9 pyrido [4',3'-4,5] thieno [3,2-f] triazolo-1,2,4 [4,3-a] diazepine-1,4] and the platelet-activating factor receptor in rabbit platelet membranes. Silva CL, Cruz HN, Violante FA, Cordeiro RS, Martins MA, Noël F. Biochem Pharmacol; 1996 Jan 26; 51(2):193-6. PubMed ID: 8615889 [Abstract] [Full Text] [Related]
14. Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs. Lagente V, Boichot E, Carre C, Guinot P, Mencia-Huerta JM, Braquet P. Clin Exp Allergy; 1993 Dec 26; 23(12):1002-10. PubMed ID: 10779293 [Abstract] [Full Text] [Related]
15. Pharmacologic profile of BN 50739, a new PAF antagonist in vitro and in vivo. Yue TL, Rabinovici R, Farhat M, Feuerstein G. Prostaglandins; 1990 May 26; 39(5):469-80. PubMed ID: 2353116 [Abstract] [Full Text] [Related]
16. Effect of Gingko biloba extract (EGb 761) on chloroquine induced retinal alterations. Droy-Lefaix MT, Vennat JC, Besse G, Doly M. Lens Eye Toxic Res; 1992 May 26; 9(3-4):521-8. PubMed ID: 1301800 [Abstract] [Full Text] [Related]
17. Effect of BN 50727 on pathological findings and tissue platelet activating factor levels during ileal ischemia in newborn piglets. de Boissieu D, Canarelli JP, Cordonnier C, Richard S, Léké A, Tarrade T, Postel JP, Dupont C. J Pediatr Surg; 1996 Dec 26; 31(12):1675-9. PubMed ID: 8986985 [Abstract] [Full Text] [Related]
19. Suppression of lipopolysaccharide-induced nitric oxide synthase expression by platelet-activating factor receptor antagonists in the rat liver and cultured rat Kupffer cells. Mustafa SB, Flickinger BD, Olson MS. Hepatology; 1999 Nov 26; 30(5):1206-14. PubMed ID: 10534342 [Abstract] [Full Text] [Related]
20. Inhibition of platelet-activating factor-induced retinal impairments by cholera and pertussis toxins. Cluzel J, Doly M, Bazan NG, Bonhomme B, Braquet P. Ophthalmic Res; 1995 Nov 26; 27(3):153-7. PubMed ID: 8538992 [Abstract] [Full Text] [Related] Page: [Next] [New Search]